Skip to content

Drug interactions

Apomorphine + Octreotide

Severity: Moderate

Apomorphine and Octreotide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Apomorphine has been associated with QT prolongation, and octreotide can cause bradycardia and conduction changes. Combined use may increase proarrhythmic risk, especially in patients with cardiac disease.

What this interaction means in plain words

Apomorphine and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Apomorphine belongs to Central Nervous System; Octreotide belongs to Endocrine.

Evidence level: Low

Why it happens

Additive effects on cardiac repolarization and conduction.

What to do

Check a baseline ECG and monitor QTc and heart rate, correcting electrolyte abnormalities. Avoid use in patients with congenital long QT or other significant QT risk factors.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Apomorphine and Octreotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Apomorphine with Octreotide?

MediHelp rates the interaction as moderate. Apomorphine and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Apomorphine has been associated with QT prolongation, and octreotide can cause bradycardia and conduction changes. Combined use may increase proarrhythmic risk, especially in patients with cardiac disease.

How serious is the interaction between Apomorphine and Octreotide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check a baseline ECG and monitor QTc and heart rate, correcting electrolyte abnormalities. Avoid use in patients with congenital long QT or other significant QT risk factors.

What other medicines interact with Octreotide?

MediHelp also lists interactions of Octreotide with, for example, Adagrasib, Amisulpride, Arsenic trioxide. The full list is on the Octreotide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in